Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-21

Clinical Trial Update: Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Conbercept Injection in treating severe proliferative diabetic retinopathy with tractional retinal detachment; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Conbercept Injection (conbercept)

Snippet

Sponsor: Ruijin Hospital | Conditions: Proliferative Diabetic Retinopathy, Tractional Retinal Detachment | Phase 4 | Status: COMPLETED | Results posted: 2019-11-21